Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 10 | 4 | IMMUNOLOGY//TRANSPLANTATION//RHEUMATOLOGY | 1369268 |
| 97 | 3 | EPSTEIN BARR VIRUS//HEMATOLOGY//LYMPHOMA | 77599 |
| 894 | 2 | EPSTEIN BARR VIRUS//EBV//POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER | 11547 |
| 13301 | 1 | GP350//JOINT ONCOL PROGRAM//EPSTEIN BARR VIRUS | 877 |
Terms with highest relevance score |
| rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|---|
| 1 | GP350 | authKW | 176080 | 1% | 70% | 7 |
| 2 | JOINT ONCOL PROGRAM | address | 129351 | 1% | 30% | 12 |
| 3 | EPSTEIN BARR VIRUS | authKW | 120413 | 15% | 3% | 130 |
| 4 | AUSTRALIAN VACCINE DEV | address | 114976 | 1% | 27% | 12 |
| 5 | EPSTEIN BARR VIRUS NUCLEAR ANTIGEN 1 | authKW | 99508 | 1% | 46% | 6 |
| 6 | TUMOUR IMMUNOL | address | 86516 | 2% | 14% | 17 |
| 7 | GLY ALA REPEAT | authKW | 82135 | 0% | 57% | 4 |
| 8 | QIMR IMMUNOTHER Y VACCINE DEV | address | 82135 | 0% | 57% | 4 |
| 9 | AUSTRALIAN VACCINE DEV TUMOUR IMMUNOL | address | 80854 | 0% | 75% | 3 |
| 10 | AUSTRALIAN VACCINE DEV TUMOR IMMUNOL | address | 71871 | 0% | 100% | 2 |
Web of Science journal categories |
| chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | Immunology | 7663 | 45% | 0% | 391 |
| 2 | Virology | 6877 | 21% | 0% | 188 |
| 3 | Oncology | 659 | 16% | 0% | 140 |
| 4 | Medicine, Research & Experimental | 644 | 11% | 0% | 98 |
| 5 | Hematology | 424 | 7% | 0% | 65 |
| 6 | Microbiology | 124 | 6% | 0% | 56 |
| 7 | Cell Biology | 124 | 8% | 0% | 71 |
| 8 | Parasitiology | 70 | 2% | 0% | 18 |
| 9 | Infectious Diseases | 57 | 3% | 0% | 28 |
| 10 | Biotechnology & Applied Microbiology | 52 | 5% | 0% | 42 |
Address terms |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | JOINT ONCOL PROGRAM | 129351 | 1% | 30% | 12 |
| 2 | AUSTRALIAN VACCINE DEV | 114976 | 1% | 27% | 12 |
| 3 | TUMOUR IMMUNOL | 86516 | 2% | 14% | 17 |
| 4 | QIMR IMMUNOTHER Y VACCINE DEV | 82135 | 0% | 57% | 4 |
| 5 | AUSTRALIAN VACCINE DEV TUMOUR IMMUNOL | 80854 | 0% | 75% | 3 |
| 6 | AUSTRALIAN VACCINE DEV TUMOR IMMUNOL | 71871 | 0% | 100% | 2 |
| 7 | CANC UK BIRMINGHAM CANC | 71867 | 0% | 50% | 4 |
| 8 | CLIVE BERGHOFER CANC | 64164 | 1% | 36% | 5 |
| 9 | EBV BIOL | 63881 | 0% | 44% | 4 |
| 10 | PL IMMUNOL MICROBIOL GRP | 47913 | 0% | 67% | 2 |
Journals |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | JOURNAL OF VIROLOGY | 4192 | 8% | 0% | 69 |
| 2 | JOURNAL OF IMMUNOLOGY | 3473 | 8% | 0% | 73 |
| 3 | COMPREHENSIVE IMMUNOLOGY | 3265 | 0% | 9% | 1 |
| 4 | PERSPECTIVES IN PEDIATRIC PATHOLOGY | 2993 | 0% | 8% | 1 |
| 5 | JOURNAL OF EXPERIMENTAL MEDICINE | 2924 | 4% | 0% | 32 |
| 6 | CELLULAR IMMUNOLOGY | 2824 | 3% | 0% | 25 |
| 7 | SEMINARS IN VIROLOGY | 2548 | 0% | 2% | 4 |
| 8 | EUROPEAN JOURNAL OF IMMUNOLOGY | 2401 | 3% | 0% | 30 |
| 9 | AIDS RESEARCH | 2142 | 0% | 3% | 2 |
| 10 | CELLULAR & MOLECULAR IMMUNOLOGY | 1983 | 1% | 1% | 7 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |